Your browser doesn't support javascript.
Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman's and Bartter's syndromes.
Bertoldi, Giovanni; Ravarotto, Verdiana; Sgarabotto, Luca; Davis, Paul A; Gobbi, Laura; Calò, Lorenzo A.
  • Bertoldi G; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Ravarotto V; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Sgarabotto L; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Davis PA; Department of Nutrition, University of California, Davis, California, USA.
  • Gobbi L; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
  • Calò LA; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
J Intern Med ; 291(4): 522-524, 2022 04.
Article in English | MEDLINE | ID: covidwho-1557763
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bartter Syndrome / Angiotensin-Converting Enzyme 2 / COVID-19 Limits: Humans Language: English Journal: J Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article Affiliation country: Joim.13426

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bartter Syndrome / Angiotensin-Converting Enzyme 2 / COVID-19 Limits: Humans Language: English Journal: J Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article Affiliation country: Joim.13426